Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured survey
Background Therapeutic drug monitoring (TDM) may lead to more rational use of biologics. Still, TDM is largely underexplored in psoriasis. Little is known about the dosing behavior of biologics by dermatologists, and their attitude toward TDM. Objective Exploration of the awareness and need for the...
Main Authors: | Lisa Schots, Lynda Grine, Rani Soenen, Jo Lambert |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-04-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2020.1832649 |
Similar Items
-
Therapeutic drug monitoring of biologics in psoriasis
by: Liau MM, et al.
Published: (2019-07-01) -
Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice
by: Rani Soenen, et al.
Published: (2022-05-01) -
Real-world use of ustekinumab therapeutic drug monitoring in moderate to severe psoriasis
by: Laida Elberdín, et al.
Published: (2022-12-01) -
Impact of Pharmacokinetic and Pharmacodynamic Properties of Monoclonal Antibodies in the Management of Psoriasis
by: Karine Rodríguez-Fernández, et al.
Published: (2022-03-01) -
Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients
by: Rajagopalan M, et al.
Published: (2022-08-01)